ACT-HF: Attention, Cognition and Self-Management in Heart Failure
ACT-HF
1 other identifier
observational
72
1 country
1
Brief Summary
This study is designed to determine if a relationship exists between problems with memory, attention, learning, insight and executive function and self management in heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2008
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 3, 2010
CompletedFirst Posted
Study publicly available on registry
February 8, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedSeptember 5, 2013
September 1, 2013
2.5 years
February 3, 2010
September 4, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Self-management of heart failure as measured by the Self-Care in Heart Failure Index
at time of enrollment
Secondary Outcomes (1)
Duration of hospitalization(s)
90 days after enrollment
Study Arms (1)
Heart failure
Outpatients with heart failure, age 75 or less, left ventricular ejection fraction 40% or less, english speaking with no known dementia
Eligibility Criteria
All patients with history of heart failure 6 months or more meeting inclusion criteria recruited from outpatient clinic who receiving routine care for their heart failure
You may qualify if:
- years of age or less
- ejection fraction 40% or less
- heart failure 6 months or more
- English speaking
- no known dementia
- no active substance abuse
- presence of caregiver/support
You may not qualify if:
- neurologic disorders potentially causing cognitive dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Chicagolead
- Sigma-Tau Research, Inc.collaborator
Study Sites (1)
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Savitri E. Fedson, MD
University of Chicago
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 3, 2010
First Posted
February 8, 2010
Study Start
September 1, 2008
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
September 5, 2013
Record last verified: 2013-09